Literature DB >> 22551308

Severe colitis while responding to ipilimumab in metastatic melanoma.

Marije Slingerland, Johan W R Nortier, Roeland A Veenendaal, Ellen Kapiteijn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22551308     DOI： 10.3109/0284186X.2012.682630

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  2 in total

1.  Anti-TNF-refractory colitis after checkpoint inhibitor therapy: Possible role of CMV-mediated immunopathogenesis.

Authors:  Katharina Lankes; Gheorghe Hundorfean; Thomas Harrer; Ansgar J Pommer; Abbas Agaimy; Irena Angelovska; Azadeh Tajmir-Riahi; Jonas Göhl; Gerold Schuler; Markus F Neurath; Werner Hohenberger; Lucie Heinzerling
Journal:  Oncoimmunology       Date:  2016-02-18       Impact factor: 8.110

Review 2.  Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis.

Authors:  Anne Bertrand; Marie Kostine; Thomas Barnetche; Marie-Elise Truchetet; Thierry Schaeverbeke
Journal:  BMC Med       Date:  2015-09-04       Impact factor: 8.775
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.